Abstract
Strontium (Sr) and related compounds have become more attractive in the prevention and treatment of osteoporosis. Previously, we developed a novel bioactive bone cement, which mainly composed of strontium-containing hydroxyapatite (Sr-HA) filler and bisphenol A diglycidylether dimethacrylate (Bis-GMA) resin. This bone cement is superior to conventional polymethylmethacrylate (PMMA) bone cement in bioactivity, biocompatibility, and osseointegration. It also has shown sufficient mechanical strength properties for its use in percutaneous vertebroplasty (PVP) and total hip replacement (THR). In this chapter, we reviewed the in vitro, in vivo, and clinical evidence for the effectiveness of this bioactive bone cement.
Related Books
Advances in Biotechnology
Bioencapsulation of Living Cells for Diverse Medical Applications
Biotechnological Production Of Natural Ingredients For Food Industry
Biotechnological Production of Plant Secondary Metabolites
Chemistry, Biology and Potential Applications of Honeybee Plant-Derived Products
Recent Advances in Biotechnology
Recent Advances in Biotechnology
Recent Advances in Biotechnology
Recent Advances in Biotechnology
Recent Advances in Biotechnology